东诚药业：12月15日召开董事会会议

Group 1 - The company Dongcheng Pharmaceutical (SZ 002675) held its sixth board meeting on December 15, 2025, to discuss the proposal for purchasing directors and officers liability insurance [1] - For the first half of 2025, the company's revenue composition is entirely from the biopharmaceutical industry, accounting for 100.0% [2] - As of the report date, Dongcheng Pharmaceutical has a market capitalization of 11.2 billion yuan [3]